A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS
Clinical trial NCT06731699 · RECRUITING
Trial details
- NCT number
- NCT06731699
- Sponsor
- Chengdu FenDi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2026-01-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.